DFDA

Antiplatelet Therapy (e.g., Aspirin)

Treatment for Vascular Intestinal Disorders

Typical Dosage: Aspirin 81mg daily

Effectiveness
65%
Safety Score
80%
Clinical Trials
1,000
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
Aspirin 81mg daily
Time to Effect
Days
Treatment Duration
Lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
75(Treat 75 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
300(Treat 300 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$50
Side Effect Mgmt:$100
Total Annual:$200
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$15,000/QALY
QALYs Gained
0.2
Comparison vs No treatment
Cost Difference
$-200/year
Less expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Antiplatelet Therapy (e.g., Aspirin) Outcomes

for Vascular Intestinal Disorders

Efficacy Outcomes
Overall Effectiveness
+65%
Common Side Effects
GI upset
+10%
Bleeding (GI)
+2%

Sources:

nih.gov
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov